Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2017 06 20; 317(23):2392-2401.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Camptothecin
Canada
Cetuximab
Colorectal Neoplasms
Disease-Free Survival
Female
Fluorouracil
Genes, ras
Humans
Kaplan-Meier Estimate
Leucovorin
Male
Middle Aged
Organoplatinum Compounds
Treatment Outcome
United States

authors with profiles

Blase Polite
Richard Schilsky